Alzheimer's: Proteomics gives clues toward alternatives to amyloid
In Alzheimer’s research, one particular protein looms large: plaque-forming amyloid-beta. Yet plaques can accumulate decades before symptoms appear, and clinical trials aimed at controlling amyloid-beta